Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Since the start of the pandemic, the CAMS-Oxford Institute (COI) has carried out 11 projects to better understand COVID-19, resulting in 21 published research articles.

The COVID-19 research projects undertaken by the COI, in collaboration with different units in the Nuffield Department of Medicine and other departments in the Medical Sciences Division, have made an impactful contribution to the understanding of COVID-19 pathology and immunology.

Below are the highlights of their research:

  • Understanding T cell responses to SARS-COV-2
    Prof. Tao Dong and her group identified the epitopes that illicit strong T-cell responses across a range of HLA types, which helped to inform vaccine design.
  • Understanding antibody responses to SARS-COV-2
    Multiple studies examined antibody responses to SARS-COV-2, and the mutations in spike protein helped to campaign for the inclusion of the omicron spike in a bivalent vaccine.
  • Understanding the effect of host genetics on disease severity
    The study identified immune signatures and correlates of host response and advanced the development of new drugs and personalised medicine approaches in the treatment of COVID-19.
  • Understanding immune responses following vaccination
    Multiple studies looked into the correlates of protection against symptomatic and asymptomatic infection, which play an integral role in the development of vaccines.
  • Understanding SARS-COV-2 pathogenesis
    In addition to the immune responses, researchers also studied viral replication, host responses, and associated COVID-19 pathogenesis.

 For more details on the research papers visit the COI Website.

Similar stories

Phase II Malaria vaccine trial begins in Thailand

The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.

New genetic mutation linked to rare conditions

Researchers from Wellcome Centre for Human Genetics at the Nuffield Department of Medicine, have discovered that a rare type of genetic variant can be responsible for two well-known skeletal disorders.

NDM student Romain Guyon awarded the 2022 Michelson Prize

DPhil student at the Jenner Institute, Romain Guyon is among the researchers who received the 2022 Michelson Prizes: Next Generation Grants, announced by Michelson Medical Research Foundation and Human Immunome Project.

The University of Oxford signs MoU with Diamond Light Source

A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness and to promote further cooperation between the University of Oxford and Diamond Light Source, the UK’s national synchrotron has been agreed upon.

Sarah Gilbert awarded 2023 King Faisal Prize

Professor Dame Sarah Gilbert, the Saïd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.

Three NDM researchers awarded Associate Professorships

We are delighted to announce that three researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.